Control of fatty acid metabolism in ischemic and hypoxic hearts. 1978

J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely

The effects of whole heart ischemia on fatty acid metabolism were studied in the isolated, perfused rat heart. A reduction in coronary flow and oxygen consumption resulted in lower rates of palmitate uptake and oxidation to CO2. This decrease in metabolic rate was associated with increased tissue levels of long chain acyl coenzyme A and long chain acylcarnitine. Cellular levels of acetyl-CoA, acetylcarnitine, free CoA, and free carnitine decreased. These changes in CoA and its acyl derivatives indicate that beta oxidation became the limiting step in fatty acid metabolism. The rate of beta oxidation was probably limited by high levels of NADH and FADH2 secondary to a reduced supply of oxygen. Tissue levels of neutral lipids showed a slight increase durning ischemia, but incorporation of [U-14C]palmitate into lipid was not altered significantly. Although both substrates for lipid synthesis were present in higher concentrations during ischemia, compartmentalization of long chain acyl-CoA in the mitochondrial matrix and alpha-glycerol phosphate in the cytosol may have accounted for the relatively low rate of lipid synthesis.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010169 Palmitic Acids A group of 16-carbon fatty acids that contain no double bonds. Acids, Palmitic
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D000105 Acetyl Coenzyme A Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. Acetyl CoA,Acetyl-CoA,CoA, Acetyl,Coenzyme A, Acetyl
D000214 Acyl Coenzyme A S-Acyl coenzyme A. Fatty acid coenzyme A derivatives that are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation. Acyl CoA,Fatty Acyl CoA,Long-Chain Acyl CoA,Acyl CoA, Fatty,Acyl CoA, Long-Chain,CoA, Acyl,CoA, Fatty Acyl,CoA, Long-Chain Acyl,Coenzyme A, Acyl,Long Chain Acyl CoA

Related Publications

J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
October 1992, Molecular and cellular biochemistry,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
January 1976, Acta medica Scandinavica. Supplementum,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
July 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
June 1981, Circulation research,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
September 1984, The American journal of physiology,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
May 1981, Circulation research,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
January 1977, Respiration; international review of thoracic diseases,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
September 1998, The American journal of physiology,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
August 1979, The Journal of clinical investigation,
J T Whitmer, and J A Idell-Wenger, and M J Rovetto, and J R Neely
June 1992, Circulation research,
Copied contents to your clipboard!